Nastech (NSTK) Provides Update on Parathyroid Hormone, P&G Amends Contract
Tweet Send to a Friend
Nastech Pharmaceutical (Nasdaq: NSTK) provided an update on Parathyroid Hormone (PTH1-34) Nasal Spray, which is under development for the treatment ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


